The Chinese screening model for asthma-chronic obstructive pulmonary disease overlap (ACO) appears to be feasible, potentially offering a simple tool for clinicians to efficiently diagnose ACO, according to a recent study.
Serum levels of S100 calcium‐binding protein A4 (S100A4) appear to be a helpful biomarker in predicting disease progression or mortality in patients with idiopathic pulmonary fibrosis (IPF), suggests a recent study.
Type 2 diabetes mellitus (T2DM) patients with HbA1c levels of 7–9 percent are at slightly higher risk of chronic obstructive pulmonary disorder (COPD) compared with their peers who have good glycaemic control, a study has found.
Use of corticosteroid is not associated with improved outcomes in idiopathic pulmonary fibrosis (IPF) patients admitted to the hospital with acute exacerbation (AE), reveals a recent study. In addition, corticosteroids may even contribute to reduced overall survival following exacerbation.
Children with controlled asthma and severe asthma appear to have slightly better school performances than their healthy counterparts, a recent study suggests. However, those with uncontrolled conditions perform worse.
MicroRNA-4508 shows promise as a diagnostic marker for silica-related pulmonary fibrosis (SPF), while its functional variant rs6576457 has been shown to influence susceptibility to SPF, according to a study.
In infants born extremely premature, immunization with palivizumab does not confer apparent protective effects on respiratory symptoms and pulmonary function at adolescence, as reported in a recent study. Nevertheless, immunized survivors of extreme prematurity show good clinical and physiological outcomes.
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Patients with psoriatic arthritis (PsA) often suffer from liver abnormalities, which are associated with higher body mass index (BMI), daily consumption of alcohol, more severe disease, and some therapies, according to a recent study.
Pembrolizumab in combination with chemotherapy significantly improves progression-free survival (PFS) vs chemotherapy alone in patients with previously untreated, locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC), results of the KEYNOTE-355 study have shown.